APO-go PEN 30mg/3ml solution for injection
BNF presentation 0409010A0BCACAX within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0409010A0BCACAX
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
808
NHS spend (£)
£292,436.78
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 88 |
| December 2024 | 18 |
| November 2024 | 119 |
| October 2024 | 98 |
| August 2024 | 9 |
| July 2024 | 109 |
| June 2024 | 1 |
| May 2024 | 19 |
| July 2021 | 45 |
| June 2021 | 39 |
| December 2020 | 128 |
| November 2020 | 135 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 14 | No data available |
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
|
Belvoir Health Group
ODS C84017
|
7 | 52R - NOTTINGHAM AND NOTTINGHAMSHIRE ICB |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 7 | No data available |